Get the Stockscreener App
19.07
0.68%
-0.13
After Hours:
19.07
Caredx Inc stock is traded at $19.07, with a volume of 319.38K.
It is down -0.68% in the last 24 hours and up +6.72% over the past month.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
See More
Previous Close:
$19.20
Open:
$19.13
24h Volume:
319.38K
Relative Volume:
0.33
Market Cap:
$980.82M
Revenue:
$312.78M
Net Income/Loss:
$-143.56M
P/E Ratio:
-7.0892
EPS:
-2.69
Net Cash Flow:
$1.22M
1W Performance:
-4.75%
1M Performance:
+6.72%
6M Performance:
-2.41%
1Y Performance:
-9.96%
1-Day Range:
$18.78
$19.33
1-Week Range:
$18.78
$19.97
52-Week Range:
$10.96
$25.95
Caredx Inc Stock (CDNA) Company Profile
Name
Caredx Inc
Sector
Industry
Phone
415-287-2300
Address
8000 MARINA BLVD, BRISBANE, CA
Compare CDNA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CDNA
Caredx Inc
|
19.07 | 987.51M | 312.78M | -143.56M | 1.22M | -2.69 |
|
TMO
Thermo Fisher Scientific Inc
|
583.45 | 219.82B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
230.67 | 162.91B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
682.32 | 54.93B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
137.62 | 39.10B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
IQV
Iqvia Holdings Inc
|
227.69 | 38.68B | 15.90B | 1.28B | 2.21B | 7.2842 |
Caredx Inc Stock (CDNA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-26-25 | Initiated | William Blair | Mkt Perform |
| Jan-15-25 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Aug-28-24 | Initiated | Wells Fargo | Underweight |
| Aug-19-24 | Upgrade | BTIG Research | Neutral → Buy |
| May-13-24 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-01-24 | Upgrade | Craig Hallum | Hold → Buy |
| Nov-09-23 | Upgrade | Stephens | Equal-Weight → Overweight |
| Aug-15-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-11-23 | Downgrade | BTIG Research | Buy → Neutral |
| Mar-07-23 | Downgrade | Stephens | Overweight → Equal-Weight |
| Mar-03-23 | Downgrade | Craig Hallum | Buy → Hold |
| Mar-03-23 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| Apr-25-22 | Initiated | Stephens | Overweight |
| Jul-20-21 | Resumed | BTIG Research | Buy |
| Jun-03-21 | Initiated | Goldman | Buy |
| Feb-26-21 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Oct-30-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-08-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-02-20 | Reiterated | H.C. Wainwright | Buy |
| Aug-05-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-26-20 | Initiated | BTIG Research | Buy |
| Jun-19-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-01-19 | Resumed | Craig Hallum | Buy |
| May-09-19 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Feb-15-19 | Initiated | Jefferies | Buy |
| Oct-23-18 | Resumed | Raymond James | Strong Buy |
| Sep-18-18 | Reiterated | H.C. Wainwright | Neutral |
| Nov-27-17 | Initiated | H.C. Wainwright | Buy |
| Jun-14-16 | Reiterated | Mizuho | Buy |
| Sep-29-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Sep-25-15 | Initiated | Craig Hallum | Buy |
| Mar-18-15 | Reiterated | Mizuho | Buy |
View All
Caredx Inc Stock (CDNA) Latest News
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Should CareDx’s Governance Settlement and ESOP Shift Require Action From CareDx (CDNA) Investors? - simplywall.st
CareDX Has Reached An Inflection Point, But Regulatory Risks Remain (Upgrade) (CDNA) - Seeking Alpha
CareDx, Inc. (NASDAQ:CDNA) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
CareDx (CDNA): Reassessing Valuation After Governance Reform Settlement and Legal Resolution Proposal - Sahm
Will CareDx Inc stock benefit from commodity pricesShare Buyback & Capital Efficient Trade Techniques - Улправда
CareDx (NASDAQ:CDNA) Rating Increased to Buy at Wall Street Zen - MarketBeat
CareDx wins preliminary court approval for derivative settlement - MSN
Short Covering: Why CareDx Inc stock is popular among millennialsJuly 2025 PostEarnings & Fast Gain Swing Trade Alerts - Улправда
Why CareDx Inc stock is in analyst buy zoneQuarterly Market Review & Free Weekly Chart Analysis and Trade Guides - Улправда
Is CareDx Inc stock a bargain at current levels2025 Pullback Review & Entry and Exit Point Strategies - Улправда
CareDx price target raised to $18 from $14 at Wells Fargo - MSN
Wells Fargo maintains CareDx (CDNA) equal-weight recommendation - MSN
Will CareDx Inc stock outperform Dow Jones index2025 Market Trends & High Win Rate Trade Alerts - Улправда
Why CareDx Inc stock is popular among millennialsMarket Performance Recap & Weekly High Conviction Trade Ideas - Улправда
CareDx (NASDAQ: CDNA) secures preliminary approval for shareholder derivative settlement - Stock Titan
CareDx provides notice of proposed derivative settlement - marketscreener.com
CareDx Provides Notice Of Proposed Derivative Settlement - TradingView — Track All Markets
CareDx Wins Preliminary Court Approval for Derivative Settlement - TipRanks
CareDx, Inc. Reaches Preliminary Settlement in Shareholder Derivative Litigation - TradingView — Track All Markets
CareDx Provides Notice of Proposed Derivative Settlement - Yahoo Finance
Squarepoint Ops LLC Has $2.77 Million Stock Holdings in CareDx, Inc. $CDNA - MarketBeat
Transplantation Market to Reach US$ 31.92 Billion by 2032 at 8.6% - openPR.com
CareDx (NASDAQ: CDNA) adopts majority voting and director resignation rules - Stock Titan
CDNA: Wells Fargo Raises Price Target to $18, Maintains Equal-We - GuruFocus
Trading the Move, Not the Narrative: (CDNA) Edition - Stock Traders Daily
CareDx (CDNA): Rethinking Valuation After a Sharp Short-Term Share Price Rebound - Yahoo Finance
Nikko Asset Management Americas Inc. Reduces Position in CareDx, Inc. $CDNA - MarketBeat
CareDx Shares Navigate Conflicting Market Signals - AD HOC NEWS
There's No Escaping CareDx, Inc's (NASDAQ:CDNA) Muted Revenues Despite A 26% Share Price Rise - 富途牛牛
CareDx, Inc. $CDNA Shares Sold by Bellevue Group AG - MarketBeat
CareDx (NASDAQ:CDNA) Lowered to "Hold" Rating by Wall Street Zen - MarketBeat
CareDx Reports Strong Q3 2025 Financial Results - MSN
Stocks Showing Improved Relative Strength: CareDx - MSN
CareDx Reforms Get Nod Following $20 Million Investor Class Deal - Bloomberg Law News
Next Century Growth Investors LLC Purchases 850,580 Shares of CareDx, Inc. $CDNA - MarketBeat
Ophir Asset Management Pty Ltd Buys 274,625 Shares of CareDx, Inc. $CDNA - MarketBeat
New York State Common Retirement Fund Acquires 64,175 Shares of CareDx, Inc. $CDNA - MarketBeat
CareDx, Inc. $CDNA Shares Bought by Hood River Capital Management LLC - MarketBeat
CareDx, Inc. $CDNA Shares Sold by Divisadero Street Capital Management LP - MarketBeat
Russell Investments Group Ltd. Has $5.06 Million Stock Holdings in CareDx, Inc. $CDNA - MarketBeat
CareDx Executive Sells Shares Under Trading Plan - TradingView — Track All Markets
Why CareDx Inc (1K9) stock remains top ratedProfit Target & Risk Managed Investment Strategies - Newser
Can CareDx Inc (1K9) stock expand revenue streamsJuly 2025 Fed Impact & Consistent Profit Focused Trading Strategies - Newser
Why CareDx Inc (1K9) stock is a strong analyst pickEarnings Beat & Low Drawdown Investment Strategies - Newser
Why CareDx Inc (1K9) stock is trending on social mediaEarnings Overview Report & Technical Entry and Exit Tips - Newser
CareDx (CDNA) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Published on: 2025-12-04 04:48:25 - Newser
What is the fair value estimate for CareDx Inc (1K9) stock in 2025CEO Change & Fast Momentum Stock Entry Tips - Newser
(CDNA) Volatility Zones as Tactical Triggers - news.stocktradersdaily.com
How CareDx Inc (1K9) stock trades in high volatilityQuarterly Investment Review & AI Enhanced Execution Alerts - Newser
Caredx Inc Stock (CDNA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.29%
0.04%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):